GSK329
GSK329 is a potent and selective small molecule inhibitor of TNNI3K. It demonstrates cardioprotective effects in models of cardiac ischemia/reperfusion injury, making it a useful research tool for studying heart failure and related cardiovascular diseases in both in vitro and in vivo experimental settings.
Product Specifications
CAS Number
1268490-12-5
Product Name Alternative
TNNI3 Interacting Kinase (TNNI3K), TNNI3K, GSK329, GSK-329, GSK 329, Inhibitor, inhibit, ischemia/reperfusion, diarylurea, cardioprotective outcomes, cardiac-specific kinase
Field of Research
Signal Transduction
Purity
97.63% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (10.59 mM) ; DMSO:250 mg/mL (529.38 mM)
Smiles
CNc1cc (Oc2c (Cl) cc (NC (=O) Nc3cccc (c3) C (F) (F) F) cc2Cl) ncn1
Molecular Formula
C19H14Cl2F3N5O2
Molecular Weight
472.25
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog